http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36518408

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 895
issn 1744-7631
1472-8222
issueIdentifier 9
pageRange 879-895
publicationName Expert Opinion on Therapeutic Targets
startingPage 879
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5ddc8d11699caba31c680fb389ea9cc5
bibliographicCitation Jiang W, Yang Z, Chen P, Zhao M, Wang Y, Wang J, Li X, Wang M, Hou P. Tolperisone induces UPR-mediated tumor inhibition and synergizes with proteasome inhibitor and immunotherapy by targeting LSD1. Expert Opinion on Therapeutic Targets. 2023 Sep 02;27(9):879–95. doi: 10.1080/14728222.2023.2259097.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8435457b51e05e49ecf69b7b9ba4b55
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e1c289714a2e13259a958bad6fa21e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e5c1533e479a3d0d634407df3577675
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_860754db7cc49d75b33fee5f2875440b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf7912e25d250fa129c415eca422ecee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af965fbafa9ace99e6c89ebc0c9cf726
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d4a5ed63725789fb4a668359bdb934b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ecc7894a3cf8644ee8e4277a51cd89d0
date 2023-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1080/14728222.2023.2259097
https://pubmed.ncbi.nlm.nih.gov/37704953
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27020
https://portal.issn.org/resource/ISSN/1744-7631
https://portal.issn.org/resource/ISSN/1472-8222
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Tolperisone induces UPR-mediated tumor inhibition and synergizes with proteasome inhibitor and immunotherapy by targeting LSD1

Total number of triples: 30.